$5.00
Manufacturer: Ukraine
Asparcam (potassium and magnesium asparaginate) is used for additional therapy for chronic heart diseases (with heart failure, in the post-infarction period), with heart rhythm disturbances, especially with ventricular arrhythmias.
Additional therapy in the treatment of digitalis preparations.
In conditions accompanied by hypokalemia and hypomagnesemia (including overdose of saluretics).
Description
Asparcam (potassium and magnesium asparaginate) tablets, 50 pcs. – Instructions for use
Ingredients
active ingredients: 1 tablet contains magnesium aspartate 0.175 g; potassium aspartate 0.175 g;
excipients: corn starch, polysorbate-80, calcium stearate, talc.
Dosage form
Pills.
Basic physical and chemical properties: white tablets with a smooth surface, flat-cylindrical, scored, with a specific odor. Marbling is allowed on the surface of the tablets.
Pharmacotherapeutic group
mineral supplements. Magnesium preparations. ATX code A12C.
Pharmacodynamics
Potassium and magnesium ions, as important intracellular cations, are involved in the work of a number of enzymes, in the process of binding macromolecules to subcellular elements, and in the mechanism of muscle contraction at the molecular level. The ratio of extra- and intracellular concentrations of potassium, calcium, sodium and magnesium ions affects the contractility of the myocardium. Aspartate, as an endogenous substance, is a carrier of potassium and magnesium ions, has a pronounced affinity for cells, and its salts undergo dissociation only slightly. As a result, ions penetrate into the intracellular space in the form of complex compounds. Potassium and magnesium asparaginate improve myocardial metabolism. Insufficient content of potassium and magnesium in the body increases the risk of developing arterial hypertension, atherosclerotic lesions of the coronary vessels, cardiac arrhythmias.
Indications
Additional therapy for chronic heart diseases (with heart failure, in the post-infarction period), with heart rhythm disturbances, especially with ventricular arrhythmias.
Additional therapy in the treatment of digitalis preparations.
In conditions accompanied by hypokalemia and hypomagnesemia (including overdose of saluretics).
Contraindications
- Hypersensitivity to the components of the drug;
- acute and chronic renal failure;
- Addison’s disease;
- hyperkalemia, hypermagnesemia;
- atrioventricular block II-III degree;
- cardiogenic shock (BP < 90 mm Hg).
Dosage and administration
The usual daily dose for adults is 1-2 tablets 3 times a day. The dose can be increased up to 3 tablets 3 times a day. Gastric juice can reduce the effectiveness of the drug, so it is recommended to take the tablets after meals.
The course of treatment is determined by the doctor.
Storage conditions
In the original packaging at a temperature not exceeding 25 0C. Keep out of the reach of children.
Package
50 tablets in blisters; 50 tablets in a blister, 1 blister in a pack.
Recent Reviews